EU grants ELIXIR participates in several EU-funded projects to drive the delivery of various bioinformatics services to the scientific community. These EU projects enable ELIXIR to collaborate with other key European and global initiatives, industry partners and ESFRI Research Infrastructures.
At the start of 2019, ELIXIR was coordinating two ongoing research projects supported by the European Union: • EXCELERATE (2015-2019), a flagship project to implement the ELIXIR first Scientific Programme. • CORBEL (2015-2020), a cluster project bringing together 13 ESFRI biomedical research infrastructures to harmonise user access to shared resources. Additional two projects coordinated by ELIXIR kicked-off in 2019: EOSC-Life and FAIRplus.
EOSC-Life (2019-2023), is a continuation of the CORBEL project, with the aim to create an open collaborative digital space for life sciences in the European Open Science Cloud (EOSC). The 13 participating ESFRI research infrastructures work together to establish a common framework for publishing their data resources and link these data to open and reusable tools and workflows accessible to users via Europe’s national and international life-science clouds. EOSC-Life will also connect users across Europe to a single login authentication and resource authorisation system and develop data policies needed to preserve and deepen the trust given by research participants and patients volunteering their data and samples. The project kicked-off in March 2019 and will run for five years until February 2023.
EU grants in numbers Number of grants ELIXIR Hub is involved in 2019: Number of grant proposals submitted in 2019: (ELIXIR-CONVERGE, B1MG as coordinator, EOSC Enhance as beneficiary)
3
11
FAIRplus (2019-2022) is a publicprivate partnership, funded by the EU’s Innovative Medicines Initiative (IMI) and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The project aims to increase the findability, accessibility, interoperability and reusability of data from selected IMI projects and internal data from pharmaceutical industry partners. The tools and guidelines developed by FAIRplus will facilitate the application of FAIR principles to life science data and will enable wider adoption of best practices in research data management. The project kicked-off in January 2019 and will run for three and a half years until June 2022. In addition, ELIXIR participated as a partner in seven EU projects: • AACR2 (Authentication and Authorisation for Research and Collaboration 2) • EOSCPilot • RI-PATH (Charting Impact Pathways of Investment in Research Infrastructures) • eTRANSAFE (Enhancing TRANslational SAFEty) • The European Joint Programme on Rare Diseases (EJP-RD) • EU-STANDS4PM (Standards for in Silico Models in Personalised Medicine) • CINECA (Common Infrastructure for National Cohorts in Europe, Canada and Africa)
3
Number of grants awarded in 2019: (ELIXIR-CONVERGE, EOSC ENHANCE, B1MG)
10
ELIXIR Annual Report 2019
ELIXIR Annual Report 2019
